Add to ORKGSeizures-suppressant effect of encapsulated BDNF-producing cells in a rat model of temporal lobe epilepsy
The neurotrophins, notably brain-derived neurotrophic factor (BDNF) and neurotrophin 3 (NT3), modula...
Objective: Neuropeptide FF (NPFF) and its receptors (NPFF1R and NPFF2R) are differentially distribut...
In the present study, the interaction between epileptogenesis and the immune system were studied in ...
One third of the epilepsies are refractory to medical treatment and, therefore, it is highly needed ...
Brain-derived neurotrophic factor (BDNF) may represent a therapeutic for chronic epilepsy, but evalu...
Brain-derived neurotrophic factor (BDNF) may represent a therapeutic for chronic epilepsy, but evalu...
To date, a variety of pharmacological treatments exists for patients suffering epilepsy, but systemi...
Temporal lobe epilepsy (TLE) is the most common type of epilepsy in adults. This neurological disord...
The Brain-Derived Neurotrophic Factor is one of the most important trophic proteins in the brain. Th...
Contemporary antiepileptic drugs are ineffective in approximately 30% of the patients. These patien...
Objective One third of epilepsy patients do not become seizure-free using conventional medication. T...
Vagus nerve stimulation (VNS) is a moderately effective treatment for intractable epilepsy. However,...
<p>Each PTZ treatment led to an accumulation of BrdU<sup>+</sup> cells in the dentate gyrus of the k...
Purpose: Several experimental models of human temporal lobe epilepsy have shown that apoptotic death...
Purpose: Vagus nerve stimulation (VNS) is a moderately effective anti-epileptic treatment. Clinicall...
The neurotrophins, notably brain-derived neurotrophic factor (BDNF) and neurotrophin 3 (NT3), modula...
Objective: Neuropeptide FF (NPFF) and its receptors (NPFF1R and NPFF2R) are differentially distribut...
In the present study, the interaction between epileptogenesis and the immune system were studied in ...
One third of the epilepsies are refractory to medical treatment and, therefore, it is highly needed ...
Brain-derived neurotrophic factor (BDNF) may represent a therapeutic for chronic epilepsy, but evalu...
Brain-derived neurotrophic factor (BDNF) may represent a therapeutic for chronic epilepsy, but evalu...
To date, a variety of pharmacological treatments exists for patients suffering epilepsy, but systemi...
Temporal lobe epilepsy (TLE) is the most common type of epilepsy in adults. This neurological disord...
The Brain-Derived Neurotrophic Factor is one of the most important trophic proteins in the brain. Th...
Contemporary antiepileptic drugs are ineffective in approximately 30% of the patients. These patien...
Objective One third of epilepsy patients do not become seizure-free using conventional medication. T...
Vagus nerve stimulation (VNS) is a moderately effective treatment for intractable epilepsy. However,...
<p>Each PTZ treatment led to an accumulation of BrdU<sup>+</sup> cells in the dentate gyrus of the k...
Purpose: Several experimental models of human temporal lobe epilepsy have shown that apoptotic death...
Purpose: Vagus nerve stimulation (VNS) is a moderately effective anti-epileptic treatment. Clinicall...
The neurotrophins, notably brain-derived neurotrophic factor (BDNF) and neurotrophin 3 (NT3), modula...
Objective: Neuropeptide FF (NPFF) and its receptors (NPFF1R and NPFF2R) are differentially distribut...
In the present study, the interaction between epileptogenesis and the immune system were studied in ...